FAAH PHARMA
A project-focused company developing a clinical asset initially for postherpetic neuralgia.
FAAH PHARMA
Industry:
Health Care Medical
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.faahpharma.com
Status:
Active
Total Funding:
0
Technology used in webpage:
Domain Not Resolving
More informations about "FAAH Pharma"
Faah Pharma Inc. · 1255 Robert-Bourassa Blvd, Suite 1610
FAAH PHARMA INC. is a federal corporation in Montreal incorporated with Corporations Canada, a division of Innovation, Science and Economic Development (ISED) Canada. The entity was …See details»
Faah Pharma Inc. · 1610-1255 boul. Robert-Bourassa, Montréal, …
FAAH PHARMA INC. is a business entity in Montréal registered with the Business Registrar (Registraire des entreprises) of Government of Quebec. The Quebec business number …See details»
FAAH Pharma - Funding, Financials, Valuation & Investors
Aug 11, 2014 A project-focused company developing a clinical asset initially for postherpetic neuralgia.See details»
FAAH Pharma Inc. announces investment from TVM Life Science …
Aug 11, 2014 FAAH Pharma Inc., today announced an investment by TVM Life Science Ventures VII investment into the company. ... Chorus is the early phase virtual drug …See details»
FAAH Pharma - Products, Competitors, Financials, Employees ...
Aug 14, 2014 FAAH Pharma is a project-focused company developing a clinical asset initially for postherpetic neuralgia. The compound is an inhibitor of fatty acid amide hydrolase or "FAAH." …See details»
FAAH Pharma - Company Profile - Tracxn
Nov 13, 2024 FAAH Pharma ranks 155th among 237 active competitors. 68 of its competitors are funded while 66 have exited. Overall, FAAH Pharma and its competitors have raised over …See details»
FAAH Pharma Inc. Announces Investment From TVM Life Science …
Aug 11, 2014 Montréal, Québec, Canada, August 11, 2014 / B3C newswire / – FAAH Pharma Inc., today announced an investment by TVM Life Science Ventures VII investment into the …See details»
FAAH Pharma - Crunchbase
A project-focused company developing a clinical asset initially for postherpetic neuralgia.See details»
FAAH Pharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore FAAH Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 3 news.See details»
Autobahn Therapeutics Acquires Clinical-Stage FAAH Inhibitor …
SAN DIEGO – May 11, 2021 – Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders, today announced it has acquired global …See details»
FAAH inhibitors | Endocannabinoid Systems | Biomedical Research …
On July 9, 2015, Biotrial, a Contract Research Organization began human phase testing of the synthetic FAAH inhibitor BIA 10-2474 for the manufacturer by recruiting 128 healthy …See details»
Bial incident raises FAAH suspicions | Nature Biotechnology
Mar 10, 2016 French authorities, in a report published on January 29, faulted Biotrial, the Rennes-based contract research organization conducting the BIA 10-2474 trial. French health …See details»
FAAH Pharma - Tech Stack, Apps, Patents & Trademarks
A project-focused company developing a clinical asset initially for postherpetic neuralgia.See details»
Jazz Pharmaceuticals Acquires SpringWorks Therapeutics' FAAH …
Oct 26, 2020 Jazz Pharmaceuticals Acquires SpringWorks Therapeutics' FAAH Inhibitor Program Jazz Gains Exclusive Global Rights to FAAH Inhibitor PF-04457845 for the Potential …See details»
The endocannabinoid hydrolase FAAH is an allosteric enzyme
Feb 10, 2020 Fatty acid amide hydrolase (FAAH) is a membrane-bound homodimeric enzyme that in vivo controls content and biological activity of N-arachidonoylethanolamine (AEA) and …See details»
Identifying FAAH Inhibitors as New Therapeutic Options for the ...
Nov 20, 2021 Chronic pain determines a substantial burden on individuals, employers, healthcare systems, and society. Most of the affected patients report dissatisfaction with …See details»
FAAH Pharma Inc. Announces Investment From TVM Life Science …
Aug 11, 2014 Chorus is the early phase virtual drug development arm of Eli Lilly and Company’s Global External R&D organization. The investment into FAAH Pharma Inc. marks the fifth …See details»
A perspective review on fatty acid amide hydrolase (FAAH) …
Feb 15, 2020 Diverse aspects has been put forward with respect to the FAAH domain structure, various amino acids involved in the FAAH catalytic mechanism, the genomic organization in …See details»